Top AFL executive's job cut in half in major shake-up
The AFL has announced a major shake-up of its executive following months of turmoil and fan unrest.
The most significant change will see Laura Kane's role as executive general manager of football operations split in half.
A second general manager of football performance is set to be appointed within weeks to help Kane with the key portfolio.
FOX FOOTY, available on Kayo Sports, is the only place to watch every match of every round in the 2025 Toyota AFL Premiership Season LIVE in 4K, with no ad-breaks during play. New to Kayo? Get your first month for just $1. Limited-time offer.
The new 'football performance' boss will be responsible for the Match Review Officer (MRO) umpiring, game analysis, player movement, laws of the game, innovation.
Footy operations, under Kane, will be responsible for operations for the AFL, AFLW, VFL, VFLW, as well as a newly formed AFL healthcare and medical team, including the league's mental health response and ongoing concussion management.
Despite the shift, AFL CEO Andrew Dillon is adamant Kane maintains a 'major leadership role'.
'Laura will continue to play a major leadership role within the AFL.' Dillon said.
The league has come under fire for its handling multiple sagas involving Port Adelaide's Willie Rioli and an umpiring cover-up over Collingwood Lachie Schultz's concussion.
Earlier this month Dillon and Kane met with a handful of AFL coaches at a pub in Melbourne to address tension from clubs, including pleas to increase the soft cap for coaching staff.
The AFL is also looking for a new chief operating officer to support CEO Andrew Dillon.
Dillon has reportedly been on the lookout for a second-in-charge with Fremantle's Simon Garlick, Sydney's Tom Harley and Western Bulldogs' Ameet Bains been linked to the position.
Umpiring, rule interpretations and suspensions remain a bone of contention for many fans.
The AFL said in a statement: 'Following the decision to appoint a Chief Operating Officer and the recent resignation of Executive General Manager Corporate Affairs, Government and Communications Brian Walsh, Mr Dillon has taken the opportunity to restructure his Executive team.
The search process for both the COO and EGM Corporate Affairs is underway.
The AFL also confirmed the departure of Inclusion and Social Policy manager Tanya Hosch after almost nine years as a member of the AFL's executive team.
Joining the AFL in 2016, Hosch was the first Indigenous person and second woman to join the League's executive ranks.
'Tanya has been tireless in her work to ensure that inclusion has been a part of everything we have done, from encouraging more Aboriginal and Torres Strait Islander peoples into the AFL industry, to supporting clubs at all levels of our game to navigate complex social issues and create policies to reduce vilification,' Dillon said.
'We have seen the benefit of Tanya's work this year as she was a consistent advocate for and a driving force behind the Indigenous All-Stars game in Perth and her leadership resulted in the AFL attaining Gold Status in the Pride in Sport awards for the first time – both achieved after years of hard work and advocacy.
'As an industry we are indebted to Tanya for making us better.'
Hosch oversaw the appointment of the first Indigenous Tribunal Member Peter Matera in 2019, and also championed the first Indigenous player statue of Nicky Winmar.
She also instigated and completed a review of anti-vilification policy within the code, which was then updated and renamed the Peek Rule and advocated for the adoption of the social inclusion clause in the current broadcast deal.
It comes as longtime AFL commissioner Richard Goyder reportedly seeks a three-year extension, with Collingwood president Jeff Browne and Swans chairman Andrew Pridham among the contenders for the league's top job.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
24 minutes ago
- News.com.au
Health Check: Whether stoic or simply too poor, Australians spurn GP visits
Doctor visits dipped in April, reversing a recovery trend Mayne Pharma threatens to go legal in takeover dispute … but peace erupts at Cann Group with settlement of legal spat We're either a healthy lot, rely on Dr Google or simply can't afford to visit a GP anymore. Take your pick as to why our doctor visitations are running below the historic trend. Medicare data for April shows a resumption of a decline in doctors' visits, thus reversing a recent recovery. Bell Potter says the 12-month rolling rate slipped back to 0.8% from 2.3% in March and now is below the long-term median 1.4% growth. In April last year, the rolling rate had dipped to -3%. The slippage was most apparent in Queensland, which shows what stoic souls they are up north. Or maybe they couldn't get to their clinics because they were hemmed in by floods. The rate of doctors' visits has a direct impact on diagnostic imaging volumes and thus is relevant for stocks such as Sonic Healthcare (ASX:SHL), Integral Diagnostics (ASX:IDX), Healius (ASX:HLS) and Australian Clinical Labs (ASX:ACL). (Healius sold its 69 medical centres to private equity firm BGH Capital for $500 million in November 2020.) Macquarie Equities says both pathology and imaging volumes grew 4% in April, year on year. But the DI providers look to be protected by more expensive procedures – 'higher fee modalities', as the firm puts it – with benefits paid rising 8% in April for pathology and 7% for imaging. On the bright side, face-to-face GP visits have held up relative to telehealth and the former is likely to result in diagnostic referrals. So it's a bit of a mixed picture. The re-elected Albo's pledge to extend bulk billing might also ramp up volumes. What will restrain the pain at Mayne? Mayne Pharma's (ASX:MYX) takeover is in the balance, with a 10-day consultation period expiring without suitor Cosette Pharmaceuticals pulling the plug. Cosette alleged that events had resulted in a 'material adverse change', thus triggering the consultation period. Mayne denies these events were material. The FDA has accused Mayne Pharma of downplaying the risks of its oral birth control pill, Nextstellis. Mayne Pharma now says the agency is satisfied the company has addressed the identified issues. Mayne is also in a tat-for-tat legal dispute with the Nasdaq-listed Therapeutics MD, relating to Mayne's purchase of assets from the latter in 2022. While Cosette is yet to walk, the terms of the scheme implementation deed (SID) enable the suitor to do so any time up to the second court hearing to approve the deal. The affair may end up in the courts in a different way, given Mayne 'intends to take all reasonable steps to enforce its rights under the SID.' This includes litigation, of course. Mayne shares this morning surged 5%, but they remain 32% below Cosette's $7.40 a share cash offer. So investors are saying the deal might have a pulse, but not at the original offer price. Cann Group pots legal settlement Medical cannabis play Cann Group (ASX:CAN) has settled a legal dispute with the NZ-listed Rua Biosciences, which had sued a Cann subsidiary over a manufacturing and supply agreement. As is the norm, the agreement is confidential but doesn't involve any money changing hands. Instead, the parties have agreed that Cann will supply 'certain medicinal cannabis products' to Rua under 'agreed market standard commercial terms.' As far as legal spats go, it sounds like a reasonable result. Across the Tasman, Rua shares were up more than 7% this morning Cann shares were about 3% off the pace, having lost 65% of their value year to date. The first Australian company to receive an Australian cannabis research and cultivation licence, Cann produces from its modern Mildura facility. But in the current oversupplied market, it's not easy being green. Radiopharm tackles HER-2 cancers Radiopharm Theranostics (ASX:RAD) has dosed the first patient in its phase I trial to treat advanced HER2-positive solid tumours. A human epidermal growth factor receptor, HER2 is expressed in a variety of tumours including some breast cancers. Dubbed Heat, the study road tests Radiopharm's lutetium isotope-based therapy. Taking place at multiple local centres, the study has the usual safety and tolerability remits. It also aims for the optimal dosage for a phase II trial, as well as early efficacy signals. 'Despite progressive improvements in the management of metastatic HER2-positive disease, the majority of patients experience disease progression on current standard of care and require further therapeutic options,' Radiopharm CEO Riccardo Canevari says. On Monday, the company said preclinical data from another program showed 'favorable biodistribution and ... maintained tumor uptake.' This one refers to its lutetium-based monoclonal antibody RV01, which targets solid tumours expressing the B7H3 protein. This one is via a joint venture with Houston's MD Anderson Cancer Center to develop at least four radiopharmaceutical products. The next step is FDA assent to run a first-in-human trial, which the company hopes to kick off in 2026.
News.com.au
24 minutes ago
- News.com.au
Break it Down: Australian Mines' Sconi project attracts critical mineral offtake interest
Australian Mines' Sconi project has piqued the interest of German commodity trader HMS Bergbau for supply of critical minerals.
News.com.au
30 minutes ago
- News.com.au
Principals given power to suspend, expel students outside school grounds
The Allan government has announced sweeping new powers for school principals across Victoria, allowing them to take further action for student behaviour outside school grounds and online. From the first day of term 3 this year, principals across Victorian schools will have expanded powers to suspend or expel students for behaviour outside the school gates and behind a screen. The change in powers is in line with NSW and South Australia, which have implemented such capacities for principals to suspend, exclude or expel students for behaviour that could affect student and staff safety. It is also in response to an increase in online abuse and harassment among students, particularly online, including deepfakes and AI-generated images. In February, police launched an investigation after a 'number of sexually explicit, digitally generated images of teenage girls who attend Gladstone Park Secondary College were circulated online'. Education Minister Ben Carroll said the change would 'send a clear message that harmful behaviour outside of school or online has consequences'. 'In Victoria, community safety comes first,' he said. 'The safety of students, teachers and school staff is our top priority – we're investing in programs that foster more respectful schools and acting to protect school communities. 'This builds on our nation-leading ban on mobile phones in schools and our support of a social media ban for kids – keeping kids safe in the classroom and online.' As part of the sweeping new powers, $4.2m will be invested to offer support for victims who experienced sexual harm and abuse from another student – either online or in person – through Sexual Assault Services Victoria. The state budget also allocated $10.4m to expand the Positive Behaviour Support program, which teaches students appropriate behaviour, develops safe learning spaces and offers support for students who require behavioural assistance.
